Currently, no unified guidelines exist for assessing tumor response in HCC patients, which can lead to excess costs from redundant imaging and ineffective therapies.
The researchers solicited 306 adults—188 in the U.S. and 118 in South Korea—for their views on contact tracing, quarantine monitoring and public mapping of sites recently visited by COVID-positive individuals.